Adaptive immunity against streptococcus pyogenes in adults involves increased IFN-γ and IgG3 responses compared with children

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1657-1664

  Mortensen, Rasmus ^a,b   Nissen, Thomas Nørrelykke ^c   Blauenfeldt, Thomas ^a   Christensen, Jan P ^b   Andersen, Peter ^a   Dietrich, Jes ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGENIC SECRETED PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 5; STREPTOCOCCAL C5A PEPTIDASE; STREPTOCOCCUS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; CYTOKINE; IMMUNOGLOBULIN G;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; COMPARATIVE STUDY; CORRELATIONAL STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PYOGENES; TH1 CELL; TH17 CELL; AGE; BLOOD; CELLULAR IMMUNITY; IMMUNOLOGY; METABOLISM; PRESCHOOL CHILD; STREPTOCOCCUS INFECTION; T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INTERFERON-GAMMA; MALE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; T-LYMPHOCYTE SUBSETS; TH1 CELLS; YOUNG ADULT;

EID: 84938944495     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500804     Document Type: Article

References (70)

1. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13: 470-511.
2. Carapetis, J. R., A. C. Steer, E. K. Mulholland, and M. Weber. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5: 685-694.
3. Caro-Aguilar, I., E. Ottinger, R. W. Hepler, D. D. Nahas, C. Wu, M. F. Good, M. Batzloff, J. G. Joyce, J. H. Heinrichs, and J. M. Skinner. 2013. Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197. Hum. Vaccin. Immunother. 9: 488-496.
4. McNeil, S. A., S. A. Halperin, J. M. Langley, B. Smith, A.Warren, G. P. Sharratt, D. M. Baxendale, M. A. Reddish, M. C. Hu, S. D. Stroop, et al. 2005. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41: 1114-1122.
5. Dale, J. B., T. A. Penfound, B. Tamboura, S. O. Sow, J. P. Nataro, M. Tapia, and K. L. Kotloff. 2013. Potential coverage of a multivalent M protein-based group A streptococcal vaccine. Vaccine 31: 1576-1581.
6. Steer, A. C., J. B. Dale, and J. R. Carapetis. 2013. Progress toward a global group a streptococcal vaccine. Pediatr. Infect. Dis. J. 32: 180-182.
7. O'Connor, S. P., D. Darip, K. Fraley, C. M. Nelson, E. L. Kaplan, and P. P. Cleary. 1991. The human antibody response to streptococcal C5a peptidase. J. Infect. Dis. 163: 109-116.
8. Todd, E. W. 1932. Antigenic streptococcal hemolysin. J. Exp. Med. 55: 267-280.
9. Lancefield, R. C. 1962. Current knowledge of type-specific M antigens of group A streptococci. J. Immunol. 89: 307-313.
10. Beachey, E. H., M. Bronze, J. B. Dale, W. Kraus, T. Poirier, and S. Sargent. 1988. Protective and autoimmune epitopes of streptococcal M proteins. Vaccine 6: 192-196.
11. Shet, A., E. L. Kaplan, D. R. Johnson, and P. P. Cleary. 2003. Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development. J. Infect. Dis. 188: 809-817.
12. Batzloff, M. R., W. A. Hayman, M. R. Davies, M. Zeng, S. Pruksakorn, E. R. Brandt, and M. F. Good. 2003. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8-and diphtheria toxoid-specific antibodies to protection. J. Infect. Dis. 187: 1598-1608.
13. Shet, A., E. Kaplan, D. Johnson, and P. P. Cleary. 2004. Human immunogenicity studies on group A streptococcal C5a peptidase (SCPA) as a potential vaccine against group A streptococcal infections. Indian J. Med. Res. 119: 95-98.
14. Guzmán, C. A., S. R. Talay, G. Molinari, E. Medina, and G. S. Chhatwal. 1999. Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI. J. Infect. Dis. 179: 901-906.
15. Turner, C. E., P. Kurupati, S.Wiles, R. J. Edwards, and S. Sriskandan. 2009. Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi. Vaccine 27: 4923-4929.
16. Ma, C. Q., C. H. Li, X. R. Wang, R. H. Zeng, X. L. Yin, H. D. Feng, and L. Wei. 2009. Similar ability of FbaA with M protein to elicit protective immunity against group A streptococcus challenge in mice. Cell. Mol. Immunol. 6: 73-77.
17. Hall, M. A., S. D. Stroop, M. C. Hu, M. A. Walls, M. A. Reddish, D. S. Burt, G. H. Lowell, and J. B. Dale. 2004. Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections. Infect. Immun. 72: 2507-2512.
18. Mak, T. W., A. Shahinian, S. K. Yoshinaga, A. Wakeham, L. M. Boucher, M. Pintilie, G. Duncan, B. U. Gajewska, M. Gronski, U. Eriksson, et al. 2003. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4: 765-772.
19. McAdam, A. J., R. J. Greenwald, M. A. Levin, T. Chernova, N. Malenkovich, V. Ling, G. J. Freeman, and A. H. Sharpe. 2001. ICOS is critical for CD40-mediated antibody class switching. Nature 409: 102-105.
20. Grimbacher, B., A. Hutloff, M. Schlesier, E. Glocker, K. Warnatz, R. Dräger, H. Eibel, B. Fischer, A. A. Schäffer, H. W. Mages, et al. 2003. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4: 261-268.
21. MacLennan, I. C. 1994. Germinal centers. Annu. Rev. Immunol. 12: 117-139.
22. de Vinuesa, C. G., M. C. Cook, J. Ball, M. Drew, Y. Sunners, M. Cascalho, M. Wabl, G. G. Klaus, and I. C. MacLennan. 2000. Germinal centers without T cells. J. Exp. Med. 191: 485-494.
23. Toellner, K. M., S. A. Luther, D. M. Sze, R. K. Choy, D. R. Taylor, I. C. MacLennan, and H. Acha-Orbea. 1998. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J. Exp. Med. 187: 1193-1204.
24. Cunningham, A. F., P. G. Fallon, M. Khan, S. Vacheron, H. Acha-Orbea, I. C. MacLennan, A. N. McKenzie, and K. M. Toellner. 2002. Th2 activities induced during virgin T cell priming in the absence of IL-4, IL-13, and B cells. J. Immunol. 169: 2900-2906.
25. Sideras, P., S. Bergstedt-Lindqvist, and E. Severinson. 1985. Partial biochemical characterization of IgG1-inducing factor. Eur. J. Immunol. 15: 593-598.
26. Snapper, C. M., and W. E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947.
27. Lu, Y. J., J. Gross, D. Bogaert, A. Finn, L. Bagrade, Q. Zhang, J. K. Kolls, A. Srivastava, A. Lundgren, S. Forte, et al. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4: e1000159.
28. Basset, A., C. M. Thompson, S. K. Hollingshead, D. E. Briles, E. W. Ades, M. Lipsitch, and R. Malley. 2007. Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect. Immun. 75: 5460-5464.
29. Fan, X., X. Wang, N. Li, H. Cui, B. Hou, B. Gao, P. P. Cleary, and B. Wang. 2014. Sortase A induces Th17-mediated and antibody-independent immunity to heterologous serotypes of group A streptococci. PLoS One 9: e107638.
30. Wang, B., T. Dileepan, S. Briscoe, K. A. Hyland, J. Kang, A. Khoruts, and P. P. Cleary. 2010. Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection. Proc. Natl. Acad. Sci. USA 107: 5937-5942.
31. Dileepan, T., J. L. Linehan, J. J. Moon, M. Pepper, M. K. Jenkins, and P. P. Cleary. 2011. Robust antigen specific th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection. PLoS Pathog. 7: e1002252.
32. Agren, K., A. Brauner, and J. Andersson. 1998. Haemophilus influenzae and Streptococcus pyogenes group A challenge induce a Th1 type of cytokine response in cells obtained from tonsillar hypertrophy and recurrent tonsillitis. ORL J. Otorhinolaryngol. Relat. Spec. 60: 35-41.
33. Kerakawauchi, H., Y. Kurono, and G. Mogi. 1997. Immune responses against Streptococcus pyogenes in human palatine tonsils. Laryngoscope 107: 634-639.
34. Price, J. D., J. Schaumburg, C. Sandin, J. P. Atkinson, G. Lindahl, and C. Kemper. 2005. Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein. J. Immunol. 175: 677-684.
35. Shaikh, N., E. Leonard, and J. M. Martin. 2010. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics 126: e557-e564.
36. Bisno, A. L. 1996. Acute pharyngitis: etiology and diagnosis. Pediatrics 97: 949-954.
37. Ebell, M. H., M. A. Smith, H. C. Barry, K. Ives, and M. Carey. 2000. The rational clinical examination: does this patient have strep throat? JAMA 284: 2912-2918.
38. Poses, R. M., R. D. Cebul, M. Collins, and S. S. Fager. 1985. The accuracy of experienced physicians' probability estimates for patients with sore throats: implications for decision making. JAMA 254: 925-929.
39. Hoffmann, S. 1992. An algorithm for a selective use of throat swabs in the diagnosis of group A streptococcal pharyngo-tonsillitis in general practice. Scand. J. Prim. Health Care 10: 295-300.
40. O'Connor, S. P., and P. P. Cleary. 1986. Localization of the streptococcal C5a peptidase to the surface of group A streptococci. Infect. Immun. 53: 432-434.
41. Chmouryguina, I., A. Suvorov, P. Ferrieri, and P. P. Cleary. 1996. Conservation of the C5a peptidase genes in group A and B streptococci. Infect. Immun. 64: 2387-2390.
42. McIver, K. S., S. Subbarao, E. M. Kellner, A. S. Heath, and J. R. Scott. 1996. Identification of isp, a locus encoding an immunogenic secreted protein conserved among group A streptococci. Infect. Immun. 64: 2548-2555.
43. Aagaard, C., T. Hoang, J. Dietrich, P. J. Cardona, A. Izzo, G. Dolganov, G. K. Schoolnik, J. P. Cassidy, R. Billeskov, and P. Andersen. 2011. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat. Med. 17: 189-194.
44. Jabara, H. H., R. Loh, N. Ramesh, D. Vercelli, and R. S. Geha. 1993. Sequential switching from mu to epsilon via gamma 4 in human B cells stimulated with IL-4 and hydrocortisone. J. Immunol. 151: 4528-4533.
45. Punnonen, J., G. Aversa, B. G. Cocks, A. N. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt, and J. E. de Vries. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90: 3730-3734.
46. Kilpinen, S., S. Laine, J. Hulkkonen, and M. Hurme. 2003. Immunoglobulin G3 and immunoglobulin M isotype plasma levels are influenced by interleukin-1alpha genotype. Scand. J. Immunol. 57: 296-302.
47. Kotowicz, K., and R. E. Callard. 1993. Human immunoglobulin class and IgG subclass regulation: dual action of interleukin-4. Eur. J. Immunol. 23: 2250-2256.
48. Aalberse, R. C., S. O. Stapel, J. Schuurman, and T. Rispens. 2009. Immunoglobulin G4: an odd antibody. Clin. Exp. Allergy 39: 469-477.
49. Banerjee, K., P. J. Klasse, R. W. Sanders, F. Pereyra, E. Michael, M. Lu, B. D. Walker, and J. P. Moore. 2010. IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines. AIDS Res. Hum. Retroviruses 26: 445-458.
50. Widhe, M., C. Ekerfelt, P. Forsberg, S. Bergström, and J. Ernerudh. 1998. IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease. Scand. J. Immunol. 47: 575-581.
51. Seder, R. A., P. A. Darrah, and M. Roederer. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8: 247-258.
52. Brock, I., K. Weldingh, E. M. Leyten, S. M. Arend, P. Ravn, and P. Andersen. 2004. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J. Clin. Microbiol. 42: 2379-2387.
53. Veckman, V., M. Miettinen, J. Pirhonen, J. Sirén, S. Matikainen, and I. Julkunen. 2004. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J. Leukoc. Biol. 75: 764-771.
54. Fujimoto, T., R. B. Duda, A. Szilvasi, X. Chen, M. Mai, and M. A. O'Donnell. 1997. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J. Immunol. 158: 5619-5626.
55. Miettinen, M., S. Matikainen, J. Vuopio-Varkila, J. Pirhonen, K. Varkila, M. Kurimoto, and I. Julkunen. 1998. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immun. 66: 6058-6062.
56. Miettinen, M., A. Lehtonen, I. Julkunen, and S. Matikainen. 2000. Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J. Immunol. 164: 3733-3740.
57. Darrah, P. A., D. T. Patel, P. M. De Luca, R.W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850.
58. Lindenstrøm, T., E. M. Agger, K. S. Korsholm, P. A. Darrah, C. Aagaard, R. A. Seder, I. Rosenkrands, and P. Andersen. 2009. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J. Immunol. 182: 8047-8055.
59. Kleinschek, M. A., K. Boniface, S. Sadekova, J. Grein, E. E. Murphy, S. P. Turner, L. Raskin, B. Desai,W. A. Faubion, R. deWaal Malefyt, et al. 2009. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 206: 525-534.
60. Zou, W., and N. P. Restifo. 2010. T(H)17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 10: 248-256.
61. Kryczek, I., A. T. Bruce, J. E. Gudjonsson, A. Johnston, A. Aphale, L. Vatan, W. Szeliga, Y. Wang, Y. Liu, T. H. Welling, et al. 2008. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J. Immunol. 181: 4733-4741.
62. Kryczek, I., M. Banerjee, P. Cheng, L. Vatan, W. Szeliga, S. Wei, E. Huang, E. Finlayson, D. Simeone, T. H. Welling, et al. 2009. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114: 1141-1149.
63. Hirota, K., J. E. Turner, M. Villa, J. H. Duarte, J. Demengeot, O. M. Steinmetz, and B. Stockinger. 2013. Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat. Immunol. 14: 372-379.
64. Nilsson, M., M. Weineisen, T. Andersson, L. Truedsson, and U. Sjöbring. 2005. Critical role for complement receptor 3 (CD11b/CD18), but not for Fc receptors, in killing of Streptococcus pyogenes by neutrophils in human immune serum. Eur. J. Immunol. 35: 1472-1481.
65. Flanagan, J. G., and T. H. Rabbitts. 1982. Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing gamma, epsilon and alpha genes. Nature 300: 709-713.
66. van Loghem, E. 1986. Allotypic markers. Monogr. Allergy 19: 40-51.
67. Falconer, A. E., R. Carson, R. Johnstone, P. Bird, M. Kehoe, and J. E. Calvert. 1993. Distinct IgG1 and IgG3 subclass responses to two streptococcal protein antigens in man: analysis of antibodies to streptolysin O and M protein using standardized subclass-specific enzyme-linked immunosorbent assays. Immunology 79: 89-94.
68. Hyland, K. A., R. Brennan, S. B. Olmsted, E. Rojas, E. Murphy, B. Wang, and P. P. Cleary. 2009. The early interferon response of nasal-associated lymphoid tissue to Streptococcus pyogenes infection. FEMS Immunol. Med. Microbiol. 55: 422-431.
69. Raeder, R. H., L. Barker-Merrill, T. Lester, M. D. Boyle, and D. W. Metzger. 2000. A pivotal role for interferon-gamma in protection against group A streptococcal skin infection. J. Infect. Dis. 181: 639-645.
70. Lefeber, D J., B. Benaissa-Trouw, J. F. Vliegenthart, J. P. Kamerling, W. T. Jansen, K. Kraaijeveld, and H. Snippe. 2003. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type. Infect. Immun. 71: 6915-6920.